$AMGN
AI 分析生成于 May 18, 2026
AI Score
Buy$AMGN
Amgen Inc.
$AMGNNASDAQHealthcareLarge-Cap
Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide focusing on inflammation, oncology, and cardiovascular disease.
Market Cap
$165B
Revenue (TTM)
$34.5B
+18.5%
Net Income (TTM)
$6.8B
+12.2%
EPS (TTM)
$12.52
P/E Ratio
24.5
Dividend Yield
2.8%
52-Week Range
$265-$335
Beta
0.58
Dimension Scores
Fundamental
78Technical
70Sentiment
74Risk / Reward
74Momentum
68Financial Health
Profitability
78moderate
Growth
75moderate
Liquidity
72moderate
Solvency
62moderate
Efficiency
76moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $AMGN
Free · No credit card required
免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。